- Home
- AIMD vs NXGL Comparison
AIMD vs NXGL Comparison
Compare AIMD & NXGL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AIMD
- NXGL
- Stock Information
- Founded
- AIMD 1984
- NXGL 1997
- Country
- AIMD United States
- NXGL United States
- Employees
- AIMD N/A
- NXGL N/A
- Industry
- AIMD Biotechnology: Pharmaceutical Preparations
- NXGL Medical/Dental Instruments
- Sector
- AIMD Health Care
- NXGL Health Care
- Exchange
- AIMD Nasdaq
- NXGL Nasdaq
- Market Cap
- AIMD 16.9M
- NXGL 18.7M
- IPO Year
- AIMD N/A
- NXGL 2021
- Fundamental
- Price
- AIMD $2.27
- NXGL $1.92
- Analyst Decision
- AIMD
- NXGL
- Analyst Count
- AIMD 0
- NXGL 0
- Target Price
- AIMD N/A
- NXGL N/A
- AVG Volume (30 Days)
- AIMD 37.4K
- NXGL 83.6K
- Earning Date
- AIMD 11-13-2025
- NXGL 11-11-2025
- Dividend Yield
- AIMD N/A
- NXGL N/A
- EPS Growth
- AIMD N/A
- NXGL N/A
- EPS
- AIMD N/A
- NXGL N/A
- Revenue
- AIMD $113,037.00
- NXGL $11,667,000.00
- Revenue This Year
- AIMD N/A
- NXGL $46.60
- Revenue Next Year
- AIMD N/A
- NXGL $47.96
- P/E Ratio
- AIMD N/A
- NXGL N/A
- Revenue Growth
- AIMD 178.19
- NXGL 73.41
- 52 Week Low
- AIMD $2.00
- NXGL $1.86
- 52 Week High
- AIMD $5.00
- NXGL $5.10
- Technical
- Relative Strength Index (RSI)
- AIMD 28.33
- NXGL 31.01
- Support Level
- AIMD $2.59
- NXGL $2.20
- Resistance Level
- AIMD $3.16
- NXGL $2.56
- Average True Range (ATR)
- AIMD 0.24
- NXGL 0.19
- MACD
- AIMD -0.11
- NXGL -0.06
- Stochastic Oscillator
- AIMD 0.00
- NXGL 7.31
About AIMD Ainos Inc.
Ainos Inc is engaged in developing biologics for the treatment of human and animal diseases. The company mainly focuses on the research of the treatment of human disease indications, particularly influenza, hepatitis C, thrombocytopenia, and other indications using natural human interferon-alpha that is administered in a proprietary low-dose oral form. Its product pipeline includes VELDONA Pet cytoprotein supplements for pets, VELDONA human therapeutics for clinical use, and telehealth-friendly POCTs powered by the AI Nose technology platform.
About NXGL NexGel Inc
NexGel Inc manufactures high water content, electron beam cross-linked, aqueous polymer hydrogels, or gels, used for wound care, medical diagnostics, transdermal drug delivery, and cosmetics. The company specializes in custom gels by capitalizing on proprietary manufacturing technologies. The gels and consumer products are manufactured using proprietary and non-proprietary mixing, coating and cross-linking technologies.